Hyperfine, Inc.

NasdaqGM HYPR

Hyperfine, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending September 30, 2024: USD 0.18

Hyperfine, Inc. Revenue Per Share is USD 0.18 for the Trailing 12 Months (TTM) ending September 30, 2024, a 33.67% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
  • Hyperfine, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 0.14, a 30.29% change year over year.
  • Hyperfine, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 0.11, a 483.56% change year over year.
  • Hyperfine, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending September 30, 2021 was USD 0.02.
Key data
Date Revenue Per Share Dividend Per Share Free Cash Flow Per Share Return on Assets (ROA)
Market news
Loading...
SV Wall Street
NasdaqGM: HYPR

Hyperfine, Inc.

CEO Ms. Maria Sainz
IPO Date Jan. 28, 2021
Location United States
Headquarters 351 New Whitfield Street
Employees 131
Sector Health Care
Industries
Description

Hyperfine, Inc. provides imaging, monitoring, and magnetic resonance imaging products. It offers Swoop Portable MR imaging system to address an unmet need in point-of-care medical imaging through a combination of hardware and software services. The company was incorporated in 2014 and is based in Guilford, Connecticut.

Similar companies

SRDX

Surmodics, Inc.

USD 34.06

0.62%

LIVN

LivaNova PLC

USD 49.95

-1.36%

IRMD

IRadimed Corporation

USD 61.36

-2.09%

ELMD

Electromed, Inc.

USD 34.30

-2.22%

APYX

Apyx Medical Corporation

USD 1.39

-6.08%

ITGR

Integer Holdings Corporation

USD 140.91

-1.01%

KIDS

OrthoPediatrics Corp.

USD 23.71

-3.85%

LUNG

Pulmonx Corporation

USD 6.43

4.55%

INGN

Inogen, Inc.

USD 10.84

-8.52%

OFIX

Orthofix Medical Inc.

USD 18.47

-2.99%

ANIK

Anika Therapeutics, Inc.

USD 17.79

-1.00%

NPCE

NeuroPace, Inc.

USD 13.66

-4.41%

StockViz Staff

February 7, 2025

Any question? Send us an email